440 related articles for article (PubMed ID: 17853866)
1. Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers.
Hubatsch I; Ragnarsson EG; Artursson P
Nat Protoc; 2007; 2(9):2111-9. PubMed ID: 17853866
[TBL] [Abstract][Full Text] [Related]
2. Chemical substituent effect on pyridine permeability and mechanistic insight from computational molecular descriptors.
Chen IJ; Taneja R; Yin D; Seo PR; Young D; MacKerell AD; Polli JE
Mol Pharm; 2006; 3(6):745-55. PubMed ID: 17140262
[TBL] [Abstract][Full Text] [Related]
3. The in vitro intestinal cell model: different co-cultured cells create different applications.
Zou X; Liu Y; Cui M; Wan Q; Chu X
J Drug Target; 2024 Mar; ():1-15. PubMed ID: 38537662
[TBL] [Abstract][Full Text] [Related]
4. Good Caco-2 cell culture practices.
Natoli M; Leoni BD; D'Agnano I; Zucco F; Felsani A
Toxicol In Vitro; 2012 Dec; 26(8):1243-6. PubMed ID: 22465559
[TBL] [Abstract][Full Text] [Related]
5. Optimization of the Caco-2 permeability assay to screen drug compounds for intestinal absorption and efflux.
Press B
Methods Mol Biol; 2011; 763():139-54. PubMed ID: 21874449
[TBL] [Abstract][Full Text] [Related]
6. A general approach to the apparent permeability index.
Palumbo P; Picchini U; Beck B; van Gelder J; Delbar N; DeGaetano A
J Pharmacokinet Pharmacodyn; 2008 Apr; 35(2):235-48. PubMed ID: 18351296
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability.
Hidalgo IJ; Raub TJ; Borchardt RT
Gastroenterology; 1989 Mar; 96(3):736-49. PubMed ID: 2914637
[TBL] [Abstract][Full Text] [Related]
8. Drug-permeability and transporter assays in Caco-2 and MDCK cell lines.
Volpe DA
Future Med Chem; 2011 Dec; 3(16):2063-77. PubMed ID: 22098353
[TBL] [Abstract][Full Text] [Related]
9. The Caco-2 cell monolayer: usefulness and limitations.
Sun H; Chow EC; Liu S; Du Y; Pang KS
Expert Opin Drug Metab Toxicol; 2008 Apr; 4(4):395-411. PubMed ID: 18433344
[TBL] [Abstract][Full Text] [Related]
10. Caco-2 cells and Biopharmaceutics Classification System (BCS) for prediction of transepithelial transport of xenobiotics (model drug: caffeine).
Smetanova L; Stetinova V; Kholova D; Kvetina J; Smetana J; Svoboda Z
Neuro Endocrinol Lett; 2009; 30 Suppl 1():101-5. PubMed ID: 20027153
[TBL] [Abstract][Full Text] [Related]
11. In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man--fact or myth.
Yee S
Pharm Res; 1997 Jun; 14(6):763-6. PubMed ID: 9210194
[TBL] [Abstract][Full Text] [Related]
12. TEER measurement techniques for in vitro barrier model systems.
Srinivasan B; Kolli AR; Esch MB; Abaci HE; Shuler ML; Hickman JJ
J Lab Autom; 2015 Apr; 20(2):107-26. PubMed ID: 25586998
[TBL] [Abstract][Full Text] [Related]
13. Validation and application of Caco-2 assays for the in vitro evaluation of development candidate drugs as substrates or inhibitors of P-glycoprotein to support regulatory submissions.
Elsby R; Surry DD; Smith VN; Gray AJ
Xenobiotica; 2008 Jul; 38(7-8):1140-64. PubMed ID: 18668443
[TBL] [Abstract][Full Text] [Related]
14. Epithelial transport of drugs in cell culture. I: A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells.
Artursson P
J Pharm Sci; 1990 Jun; 79(6):476-82. PubMed ID: 1975619
[TBL] [Abstract][Full Text] [Related]
15. Caco-2 cell monolayers as a model for drug transport across the intestinal mucosa.
Hilgers AR; Conradi RA; Burton PS
Pharm Res; 1990 Sep; 7(9):902-10. PubMed ID: 2235888
[TBL] [Abstract][Full Text] [Related]
16. A protocol for differentiation of human intestinal Caco-2 cells in asymmetric serum-containing medium.
Ferruzza S; Rossi C; Scarino ML; Sambuy Y
Toxicol In Vitro; 2012 Dec; 26(8):1252-5. PubMed ID: 22265977
[TBL] [Abstract][Full Text] [Related]
17. MDCK (Madin-Darby canine kidney) cells: A tool for membrane permeability screening.
Irvine JD; Takahashi L; Lockhart K; Cheong J; Tolan JW; Selick HE; Grove JR
J Pharm Sci; 1999 Jan; 88(1):28-33. PubMed ID: 9874698
[TBL] [Abstract][Full Text] [Related]
18. New perspectives on mechanisms involved in generating epithelial cell polarity.
Yeaman C; Grindstaff KK; Nelson WJ
Physiol Rev; 1999 Jan; 79(1):73-98. PubMed ID: 9922368
[TBL] [Abstract][Full Text] [Related]
19. Caco-2 cells as a model for intestinal absorption.
Angelis ID; Turco L
Curr Protoc Toxicol; 2011 Feb; Chapter 20():Unit20.6. PubMed ID: 21400683
[TBL] [Abstract][Full Text] [Related]
20. A three-dimensional coculture of enterocytes, monocytes and dendritic cells to model inflamed intestinal mucosa in vitro.
Leonard F; Collnot EM; Lehr CM
Mol Pharm; 2010 Dec; 7(6):2103-19. PubMed ID: 20809575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
